The Latest Cbd Oil Industry Statistics Explained
The global market for cannabidiol (CBD) oil is forecasted to grow from $967.2 million in 2020 to $5.3 billion by 2025, at a compound annual growth rate (CAGR) of 40.4%.
The statistic indicates that the global market for cannabidiol (CBD) oil is projected to experience significant growth over the period from 2020 to 2025. Specifically, the market is expected to expand from $967.2 million in 2020 to $5.3 billion by 2025. This growth corresponds to a compound annual growth rate (CAGR) of 40.4%, highlighting the rapid pace at which the market is anticipated to increase in value annually. Factors driving this growth may include increasing consumer awareness of the potential health benefits of CBD oil, regulatory changes that are facilitating the market, and the expanding range of products incorporating CBD oil. Overall, these projections suggest substantial opportunities for businesses operating in the CBD oil market and underscore the rising demand and interest in CBD products globally.
The U.S. holds the leading position in the global CBD oil market and generated a $737.87 million in 2019.
The statistic indicates that the United States is the top player in the worldwide CBD oil market, having generated a substantial revenue of $737.87 million in 2019. This suggests that the U.S. has a significant share of the global CBD oil industry and is a key contributor to its overall growth and development. The high revenue figure demonstrates the strong demand for CBD oil products within the U.S. market and highlights the country’s position as a major consumer and producer of CBD oil. Additionally, the statistic may also suggest that the U.S. has a competitive advantage in terms of market presence, reach, and product innovation within the CBD oil industry.
Over 64 million Americans have tried CBD in the past 24 months (as of 2019).
The statistic that over 64 million Americans have tried CBD in the past 24 months as of 2019 indicates a significant level of interest and use of cannabidiol (CBD) products among the American population. This suggests a growing trend in the adoption of CBD as a potential remedy for various health and wellness concerns. The large number of individuals experimenting with CBD in such a relatively short period reflects the increasing popularity and mainstream acceptance of CBD products in the United States. This statistic underscores the importance of further research and regulation in the CBD industry to ensure consumer safety and effectiveness of these products.
By 2024, the CBD industry is projected to hit $20 billion in sales.
The statistic “By 2024, the CBD industry is projected to hit $20 billion in sales” indicates a significant growth and expansion of the industry within the next few years. This projection suggests that the market for CBD products is expected to experience a rapid rise in sales volume, reaching a total value of $20 billion by the specified year. This data implies a strong consumer demand for CBD products and a potentially lucrative opportunity for businesses operating in this industry. Factors driving this growth may include increased awareness about the potential health benefits of CBD, changing regulations, and an expanding range of CBD products available in the market. Overall, this statistic highlights the strong potential for growth and profitability within the CBD industry in the coming years.
42% of baby boomers use CBD oil for chronic pain.
The statistic that 42% of baby boomers use CBD oil for chronic pain indicates a relatively high prevalence of CBD oil usage among individuals born between 1946 and 1964 who are experiencing chronic pain. This suggests a notable interest and adoption of alternative or complementary approaches to managing chronic pain outside of traditional pharmaceutical options. It also reflects a potential shift towards natural remedies and potentially reflects baby boomers seeking solutions that align with their preferences or values. Additionally, this statistic highlights the increasing popularity and acceptance of CBD products within this demographic as a potential solution for managing chronic pain.
COVID-19 impact pushed the CBD oil sales up to around 20% in 2020.
The statistic indicates that the impact of the COVID-19 pandemic led to a considerable increase in CBD oil sales, with a rise of approximately 20% in 2020 compared to previous years. This surge in sales can be attributed to various factors related to the pandemic, such as heightened stress and anxiety levels among the population, increased focus on health and wellness, and the shift towards alternative remedies for managing mental and physical well-being. The statistic reflects the trend of individuals turning to CBD oil as a potential solution for coping with the challenges brought about by the pandemic, highlighting the significance of the product in meeting the evolving needs of consumers during this unprecedented time.
40% of U.S. adults are interested in trying CBD oil.
The statistic “40% of U.S. adults are interested in trying CBD oil” indicates the level of potential consumer demand for CBD oil among the adult population in the United States. This suggests that a significant portion of adults in the country are open to exploring or incorporating CBD oil into their health and wellness routines. The statistic reflects a growing interest in alternative and natural health remedies, as well as an increasing awareness of CBD oil and its potential benefits. Understanding the level of interest can provide valuable insights for businesses in the CBD industry, as well as policymakers and healthcare professionals looking to address consumer preferences and needs in this market segment.
Vaping CBD oil is considered the easiest way to consume CBD with 37% of people choosing this method.
The statistic indicates that among those who consume CBD, 37% of individuals find vaping CBD oil to be the most convenient method. Vaping involves inhaling vapor produced by heating CBD oil, which allows for quick absorption into the bloodstream. The popularity of vaping CBD oil may be attributed to its ease of use, portability, and rapid effects compared to other consumption methods like edibles or sublingual tinctures. This statistic suggests that a significant portion of the population prefers vaping as a way to incorporate CBD into their wellness routines, highlighting the appeal of this method for CBD consumption.
The tincture segment held the largest revenue share of 73.8% in the CBD oil market in 2020 in the U.S.
In 2020, the tincture segment of the CBD oil market in the U.S. held the largest revenue share, accounting for 73.8% of the total market revenue. This statistic indicates that tinctures, which are CBD oil products typically consumed orally by placing drops under the tongue, were the most popular and lucrative category within the CBD oil market. The significant revenue share suggests that consumers in the U.S. showed a strong preference for tinctures over other forms of CBD oil products such as capsules, topicals, or edibles. This information is valuable for industry stakeholders and businesses looking to capitalize on the growing CBD market by understanding consumer preferences and market dynamics in order to make informed business decisions.
Experts anticipated that the passage of the 2018 United States Farm Bill would help the CBD industry grow by over $22 billion by 2022.
This statistic suggests that industry experts predicted a substantial growth in the CBD industry following the passage of the 2018 United States Farm Bill, estimating a potential increase of over $22 billion in revenue by the year 2022. The Farm Bill, which legalized the cultivation and sale of industrial hemp and its derivatives such as CBD, was expected to create new opportunities for businesses operating in the CBD sector. The significant projected growth indicates a high level of confidence in the industry’s potential for expansion, driven by increased consumer demand and regulatory changes that facilitate the production and sale of CBD products. The statistic underscores the economic impact and market opportunities that the Farm Bill was anticipated to bring to the CBD industry within a relatively short timeframe.
In 2019, 40% of CBD users utilized CBD oil for general wellness rather than treating a medical condition.
The statistic indicates that in 2019, 40% of individuals who used CBD products did so for general wellness purposes rather than to address a specific medical condition. This suggests that a significant portion of CBD users are incorporating CBD oil into their daily routines to potentially promote overall well-being and health, rather than strictly relying on it as a treatment for specific ailments. The finding highlights the growing trend of individuals turning to CBD products as a proactive approach to maintaining their health and quality of life. It also underscores the diverse range of reasons people are using CBD, beyond just managing medical symptoms.
36% of the people, who have used CBD, say it worked well without the use of conventional medicines.
The statistic indicates that 36% of individuals who have used CBD (cannabidiol) found it effective in managing their health issues without relying on conventional medicines. This suggests that a substantial portion of CBD users perceive positive benefits from using this alternative treatment method. The statistic implies that CBD may have potential efficacy as a standalone remedy for certain conditions, prompting users to forego traditional medications. However, it’s important to consider individual differences in response to treatment and consult with healthcare professionals before making decisions about medication management.
Medicinal cannabis market growth is predicted to be at 30% CAGR by 2027 globally.
This statistic indicates that the medicinal cannabis market is projected to experience significant growth over the period between the current year and 2027 with a Compound Annual Growth Rate (CAGR) of 30%. This suggests that the market for medicinal cannabis products is expected to expand rapidly due to factors such as increasing acceptance and legalization of cannabis for medical use in various countries, growing awareness of its potential health benefits, and advancements in research and development of cannabis-based pharmaceuticals. The 30% CAGR signifies a consistent and substantial rate of growth over the forecast period, indicating a strong and promising outlook for the global medicinal cannabis industry.
In 2019, Cowen & Co. estimated that sales of CBD consumer products will reach between $600 million and $2 billion.
The statistic provided states that in 2019, Cowen & Co. estimated that the sales of CBD consumer products were projected to fall within the range of $600 million to $2 billion. This indicates a significant potential market size for CBD products in 2019, reflecting the growing popularity and consumer interest in CBD-based goods. The wide range of the estimate, from $600 million to $2 billion, reflects the uncertainties and variability in the market at the time of the estimate. Factors such as regulatory changes, consumer trends, and market competition could have influenced the final sales figures within this range. Overall, this statistic highlights the expanding market opportunities and financial potential associated with CBD consumer products in 2019.
7% of Americans are currently using CBD, a figure expected to grow to 10% by 2025.
The statistic indicates that currently, 7% of Americans are utilizing CBD products, such as oils, creams, or edibles, for various purposes such as pain relief, anxiety reduction, or improved sleep. This percentage is projected to increase to 10% by the year 2025, suggesting a growing trend in the adoption of CBD products. This anticipated growth may be driven by factors such as increased awareness of the potential health benefits of CBD, changing attitudes towards cannabis-based products, and expanded availability of CBD products in the market. As such, the statistic highlights the rising popularity and acceptance of CBD among the American population, with a notable increase expected over the next few years.
Around 92% of the sales in the CBD market came from B2C in 2019.
This statistic indicates that in 2019, approximately 92% of the total sales within the CBD market were generated through business-to-consumer (B2C) transactions. This suggests that the majority of purchases of CBD products originated from individual consumers rather than from business-to-business (B2B) transactions. This information is important for businesses operating in the CBD market to understand the significant role that consumer demand plays in driving sales within the industry. It also highlights the potential opportunities for companies to focus their marketing and distribution strategies towards catering to the preferences and needs of individual consumers in order to maximize their sales in this market segment.
References
0. – https://www.www.mordorintelligence.com
1. – https://www.www.globenewswire.com
2. – https://www.healthtechzone.com
3. – https://www.www.forbes.com
4. – https://www.www.rollingstone.com
5. – https://www.www.health.com
6. – https://www.www.marketsandmarkets.com
7. – https://www.www.consumerreports.org
8. – https://www.www.entrepreneur.com
9. – https://www.vaping360.com
10. – https://www.qz.com
11. – https://www.www.cnbc.com
12. – https://www.www.fortunebusinessinsights.com
13. – https://www.www.researchandmarkets.com
